Trial site
Yekaterinburg
- 18running trials
- 11closed trials
The trials here
What the 30 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Asthma4 trials
- Amyloidosis2 trials
- Childhood cancers2 trials
- Chronic lymphocytic leukaemia2 trials
- COPD2 trials
- Heart failure2 trials
- Liver and biliary tract cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Chronic kidney disease1 trial
- and 7 more
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Active, not recruiting12 trials
- Completed9 trials
- Recruiting6 trials
- Terminated2 trials
- Suspended1 trial
- Lead sponsor
- AstraZeneca29 trials
- Acerta Pharma BV1 trial
Running trials
Recruiting
ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia
Recruiting
TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
Recruiting
Recruiting
Recruiting
Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
Active, not recruiting
A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)
Active, not recruiting
Active, not recruiting
Recruiting
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma2 recruiting
- Bladder cancer1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Endometrial cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia
Terminated
Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026